John Solomon @jsolomonReports
FDA cheerleads bivalent boosters, Paxlovid as research and ‘rebounds’ raise efficacy doubts | Just The News https://t.co/Pl0GXcbytJ — PolitiTweet.org
Created
Mon Nov 07 13:25:11 +0000 2022
Likes
83
Retweets
29
Source
Hootsuite Inc.
View Raw Data
JSON DataView on Twitter
Likely Available
John Solomon @jsolomonReports
FDA cheerleads bivalent boosters, Paxlovid as research and ‘rebounds’ raise efficacy doubts | Just The News https://t.co/Pl0GXcbytJ — PolitiTweet.org